Charles Pauling Semba - 02 Jan 2025 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role: Director
Signature: /s/ Amy E. Culbert, attorney-in-fact
Issuer symbol: DMAC
Transactions as of: 02 Jan 2025
Net transactions value: +$28,249
Form type: 4
Filing time: 03 Jan 2025, 16:15:16 UTC
Previous filing: 03 Jun 2024
Next filing: 03 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DMAC	Voting Common Shares, no par value per share	Award	$28,249	+5,290	+13%	$5.34	44,608	02 Jan 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are issuable upon vesting and settlement of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.
F2	Includes 5,290 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan.

Content

These shares are issuable upon vesting and settlement of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.

Includes 5,290 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan.